Phase II Trial of Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer.

Trial Profile

Phase II Trial of Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2011

At a glance

  • Drugs Endostatin (Primary) ; Cisplatin; Epirubicin; Fluorouracil
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Aug 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 27 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top